Meeting
2023 ASCO Quality Care Symposium
Biomarker testing rates among metastatic cancer patients with receipt of anti-cancer systemic therapy: A real-world data analysis.
Authors
Stacey DaCosta Byfield
Optum, Eden Prairie, MN
Stacey DaCosta Byfield, Bela Bapat, Laura Becker, Brock Schroeder, Ismini Chatzitheofilou, Damon Hostin, Carolina Reyes, John Leonard Fox
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B
Track
Health Care Access, Equity, and Disparities,Technology and Innovation in Quality of Care,Palliative and Supportive Care
Sub Track
Real-World Evidence
Citation
JCO Oncol Pract 19, 2023 (suppl 11; abstr 550)
DOI
10.1200/OP.2023.19.11_suppl.550
Abstract #
550
Poster Bd #
L25
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Clinical outcomes among patients with advanced non-small cell lung cancer who received targeted therapy in a real-world setting.
First Author: Mo Yang
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Cytoreductive surgery and HIPEC in colorectal cancer peritoneal metastases (CRPM): Real-world outcomes in systemic anticancer treatment–naïve patients.
First Author: Nadina Tinsley
Poster
2020 ASCO Quality Care Symposium
Readiness of health care systems to generate RWE: Frequency of radiographic imaging of metastatic disease during first-line systemic therapy.
First Author: Brandon Chan
Poster
2016 ASCO Annual Meeting
Real-world overall survival in advanced melanoma from the IMAGE study.
First Author: Mark R. Middleton